Skip to content

Model Tsx-301B Aquilion CT System

by Toshiba America Medical Systems, In.C

510(k) K083282

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

8 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK083282 Date12 Dec 2008ClearedStatusActive

Recalls

8 recalls · FDA

  • 2 recalls, same reason

    • Terminated Z-1035-2012 FDA Not yet classified initiated 3 Jan 2012
    • Terminated Z-1034-2012 FDA Not yet classified initiated 3 Jan 2012

    The recall was initiated because Toshiba has confirmed that their is a potential software issue for the TSX-301A Aquilon One and the TSX-301B Aquilon One.

    • Terminated Z-3195-2011 FDA Unclassified (pre-2012) initiated 22 Jun 2011

    Toshiba America Medical Systems is initiating a field correction on their TSX-301B: AQUILION Premium; System, X-Ray, Tomography, Computed, TSX-301A: AQUILION One; System, X-Ray, Tomography, Computed, TSX-20IA: AQUlLlON LB; System, X-Ray, Tomography, Computed, and TSX-1O1A: AQUILION 16; System, X-Ray, Tomography, Computed due to several software issues that cause the scanners to function incorr

  • 2 recalls, same reason

    • Terminated Z-2895-2011 FDA Unclassified (pre-2012) initiated 7 Jan 2011
    • Terminated Z-2896-2011 FDA Unclassified (pre-2012) initiated 7 Jan 2011

    Toshiba America Medical Systems (TAMS) is initiating a field correction for the TSX-301A and TSX-301B: Aquilion 64 System, X-Ray, Tomography because communication between reconstruction units in the system console may be broken due to failure of the optical conversion connector, resulting in a break of communication between units.

    • Terminated Z-1257-2011 FDA Unclassified (pre-2012) initiated 7 Sep 2010

    Incorrect Dose Calculation. The software that performs the pre-scan dose calculation uses an incorrect parameter for an exam Plan using a tube voltage of 80kV or 100kV. This results in a pre-scan expected dose that is approximately 10% lower than what the displayed value should be when the scanner executes the exam Plan.

    • Terminated Z-1665-2011 FDA Unclassified (pre-2012) initiated 22 Jul 2010

    Toshiba America Medical Systems (TAMS) has found that communication may be cut off in the Aquilion ONE/ Premium Systems, owing to the failure of a part used in the console.

    • Terminated Z-0907-2010 FDA Unclassified (pre-2012) initiated 7 Jan 2010

    When W-Volume is performed in Prospective CTA or Target CTA studies with ECG gating, unnecessary intervals may be set before starting the volume scan. As a result, scanning cannot be performed at the appropriate timing of constant enhancement and clinically useful images may not be obtained.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
JAK
Device Class
Class II
Regulation
21 CFR Part 892.1750
Advisory Committee
Radiology
FDA Decision
SESE Substantially Equivalent

Other devices from Toshiba America Medical Systems, In.C

See all devices from Toshiba America Medical Systems, In.C →